Molecular Partners AG

Molecular Partners AG

MLLCF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$153.69M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Molecular Partners AGMolecular Partners AG-1.8--108%-0.1
$2.86

Current Fair Value

28.6% downside

Overvalued by 28.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$153.69 Million
Enterprise Value$98.93 Million
Earnings per Share$-1.65
Beta0.68
Outstanding Shares38,326,000

Return

Return on Equity-108.40%ROE
Return on Assets-85.12%
Return on Invested Capital-101.21%

Valuation & Multiples

P/E Ratio-1.78P/E Ratio
PEG164.39PEG
Price to Sales-Price to Sales
Price to Book Ratio4.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-1.77
Enterprise Value to Net Income-2
Total Debt to Enterprise0.03
Debt to Equity0.05Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 30, 2026
EPS Estimate
-$0.40
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 5, 2027
EPS Estimate
-$0.43
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Molecular Partners AG

149 employees
CEO: Patrick Amstutz

Molecular Partners AG is a clinical-stage biopharmaceutical company that specializes in the discovery, development, and commercialization of novel therapeutic proteins, leveraging its proprietary DARPin® technology. Its pipeline features...